Viking Therapeutics Inc
SWB:1VT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Viking Therapeutics Inc
SWB:1VT
|
US |
|
SM Prime Holdings Inc
OTC:SPHXF
|
PH |
|
E
|
Essential Utilities Inc
SWB:A2A
|
US |
|
D
|
DTE Energy Co
XBER:DGY
|
US |
|
P
|
PTC Inc
SWB:PMTA
|
US |
|
K
|
Konami Group Corp
XMUN:KOA
|
JP |
|
Z
|
Zimmer Biomet Holdings Inc
F:ZIM
|
US |
|
Q
|
Quebecor Inc
TSX:QBR.A
|
CA |
|
A
|
Adobe Inc
BMV:ADBE
|
US |
|
Abb Ltd
SIX:ABBN
|
CH |
|
E
|
Estee Lauder Companies Inc
LSE:0JTM
|
US |
|
P
|
PTC Inc
XBER:PMTA
|
US |
|
B
|
Best Buy Co Inc
DUS:BUY
|
US |
|
A
|
Amdocs Ltd
F:AOS
|
US |
|
Coles Group Ltd
ASX:COL
|
AU |
|
Micron Technology Inc
NASDAQ:MU
|
US |
Bankruptcy Probability
Viking Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Viking Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Viking Therapeutics Inc
NASDAQ:VKTX
|
4.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
446.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
198.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
168.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
126.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
70.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Viking Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Viking Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
